24
Participants
Start Date
January 18, 2022
Primary Completion Date
December 30, 2022
Study Completion Date
December 30, 2025
CAR-T Cell Injection
intravenously once, and the dose group was 3.0 × 10\^6cells/kg、9.0 × 10\^6cells/kg、1.5 × 10\^7cells/kg。
Fludarabine
Fludarabine 25\~30mg/m2/d was infused intravenously for 3 consecutive days. (- 5 days to - 3 days)
cyclophosphamide
250\~350mg/m2/d cyclophosphamide was infused intravenously for 3 consecutive days. (- 5 days to - 3 days)
RECRUITING
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
Guangzhou Bioresette Biomedical Technology Co., Ltd.
INDUSTRY
The Affiliated Hospital of Xuzhou Medical University
OTHER